The role of the human ABCG2 multidrug transporter and its variants in cancer therapy and toxicology
- 1 March 2006
- journal article
- review article
- Published by Elsevier in Cancer Letters
- Vol. 234 (1) , 62-72
- https://doi.org/10.1016/j.canlet.2005.01.061
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Multidrug Transporter ABCG2 Prevents Tumor Cell Death Induced by the Epidermal Growth Factor Receptor Inhibitor Iressa (ZD1839, Gefitinib)Cancer Research, 2005
- Single amino acid (482) variants of the ABCG2 multidrug transporter: major differences in transport capacity and substrate recognitionBiochimica et Biophysica Acta (BBA) - Biomembranes, 2005
- Single amino acid substitutions in the transmembrane domains of breast cancer resistance protein (BCRP) alter cross resistance patterns in transfectantsInternational Journal of Cancer, 2003
- Catalog of 605 single-nucleotide polymorphisms (SNPs) among 13 genes encoding human ATP-binding cassette transporters: ABCA4, ABCA7, ABCA8, ABCD1, ABCD3, ABCD4, ABCE1, ABCF1, ABCG1, ABCG2, ABCG4, ABCG5, and ABCG8Journal of Human Genetics, 2002
- Multidrug resistance in cancer: role of ATP–dependent transportersNature Reviews Cancer, 2002
- Transport of 7-Ethyl-10-hydroxycamptothecin (SN-38) by Breast Cancer Resistance Protein ABCG2 in Human Lung Cancer CellsBiochemical and Biophysical Research Communications, 2001
- Pharmacogenetics and pharmacogenomicsBritish Journal of Clinical Pharmacology, 2001
- The Product of the ABC Half-Transporter Gene ABCG2 (BCRP/MXR/ABCP) Is Expressed in the Plasma MembraneBiochemical and Biophysical Research Communications, 2000
- P-glycoprotein—A mediator of multidrug resistance in tumour cellsEuropean Journal Of Cancer, 1996
- ABC Transporters: From Microorganisms to ManAnnual Review of Cell Biology, 1992